Field Safety Notice Saraco Industries Clinigo Wipes Contamination (ICN 3303)

• Saraco Industries has issued a Follow Up Report to their Voluntary Withdrawal Notice from March 2026.
• The supplier has conducted post-recall manufacturing and testing of the affected products.
• Based on the evidence of the suppliers testing, supply of VEP001 and VEP003 is expected to resume in early July 2026.
• Please see our Downloads ▼ section to access the Follow Up Report.
• VEP004 has been delisted and is no longer available to order.
• Potential indirect alternative products are available to order through our online catalogue:
  • VEP85104 – Wipe Patient Wet Hands & face 45gsm 150 x 180mm plastic free 100% viscose non-maceratable 30 wipes per pack
• Where potential alternatives are identified, Customers are advised to consult your own clinical experts to ensure suitability for your organisation’s use of these products.
• See our Downloads ▼ section to access the product listing for further information on the affected products and potential alternatives.

NHSSC: 120

Alert:

• Saraco Industries has issued a Voluntary Withdrawal Notice regarding specific batches of Clinigo Wipes.
• Following a number of complaints, the supplier identified sporadic mould contamination in the affected batches.
• Their preliminary investigations have confirmed the presence of Penicillium mould species.

Products Affected:

• Three products are affected.
• Three affected products are available via the stocked route from NHS Supply Chain.

• Please see the suppliers Withdrawal Notice for information on the affected lot numbers.
• NHS Supply Chain stock has been checked and all the affected products quarantined.
• These products are suspended and unavailable to order.
• We are expecting supply to resume towards the end of May 2026.
• Potential indirect alternatives are available. We are working with suppliers to look at bolstering the alternatives to support the supply disruption.
• See our Downloads ▼ section to access the product listing for further information on the affected product and potential alternatives.
• Where potential alternatives are identified, customers are advised to consult your own clinical experts to ensure suitability for your organisation’s use of these products.

Next Steps:

• Read and follow the full instructions in the Voluntary Withdrawal Notice and share with all users of the affected products.
• Cease use and quarantine all the affected batch numbers.
• Contact your local NHS Supply Chain Customer Services Advisor with full details of the affected products in your possession, including product codes, lot numbers and quantity. Your Customer Services Advisor will give you a unique CMS log number.
• Dispose of the affected products in accordance with your local regulations.
• Upon written confirmation of disposal in the form of an email, quoting the CMS reference, your Customer Services Advisor will raise the appropriate credit.

If you have any further questions, please contact your local NHS Supply Chain Customer Service Advisor or the Acute team.

Please be aware that in the event of a Field Safety Notice/Product Recall we may need to provide manufacturers, UK responsible Persons and Distributers with contact details of customers who have potentially received the affected stock. This is to help them to reconcile their stock and evidence to the regulators that all actions have been taken to ensure that the unused products have been removed from customers to prevent inadvertent use of faulty and potentially unsafe products.